XENE - Xenon Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

XENE is currently covered by 9 analysts with an average price target of $59.33. This is a potential upside of $15.23 (34.54%) from yesterday's end of day stock price of $44.1.

Xenon Pharmaceuticals's activity chart (see below) currently has 117 price targets and 111 ratings on display. The stock rating distribution of XENE is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 48.88% with an average time for these price targets to be met of 436.05 days.

Highest price target for XENE is $60, Lowest price target is $43, average price target is $54.22.

Most recent stock forecast was given by TESSA ROMERO from JPMORGAN on 18-Nov-2025. First documented stock forecast 01-Dec-2014.

Currently out of the existing stock ratings of XENE, 19 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$60

$15.28 (34.17%)

$60

1 months 3 days ago
(18-Nov-2025)

0/5 (0%)

$19.39 (47.75%)

Buy

$55

$10.28 (22.99%)

$55

1 months 17 days ago
(04-Nov-2025)

8/15 (53.33%)

$13.88 (33.75%)

450

Buy

$58

$13.28 (29.70%)

$55

1 months 17 days ago
(04-Nov-2025)

5/20 (25%)

$16.88 (41.05%)

492

Buy

$43

$-1.72 (-3.85%)

$43

4 months 9 days ago
(12-Aug-2025)

10/14 (71.43%)

$7.01 (19.48%)

364

Buy

$47

$2.28 (5.10%)

$55

7 months 8 days ago
(13-May-2025)

1/3 (33.33%)

$17.4 (58.78%)

438

Show more analysts

Please expand the browser size to see the chart

What is XENE (Xenon Pharmaceuticals) average time for price targets to be met?

On average it took 436.05 days on average for the stock forecasts to be realized with a an average price target met ratio 48.88

Which analyst has the current highest performing score on XENE (Xenon Pharmaceuticals) with a proven track record?

ANDREW TSAI

Which analyst has the most public recommendations on XENE (Xenon Pharmaceuticals)?

Andrew Tsai works at JEFFERIES and has 4 price targets and 3 ratings on XENE

Which analyst is the currently most bullish on XENE (Xenon Pharmaceuticals)?

Josh Schimmer with highest potential upside - $20.28

Which analyst is the currently most reserved on XENE (Xenon Pharmaceuticals)?

Maury Raycroft with lowest potential downside - -$10.24

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?